Lassila Riitta

Riitta Lassila is a distinguished Finnish physician-scientist and Professor of Coagulation Medicine at the University of Helsinki and Helsinki University Hospital. She operates as a professional entity providing expert clinical consultation, research leadership, and trial oversight in the fields of hematology and vascular biology. Her expertise focuses on thrombosis, hemostasis, and platelet function, and she has been a key investigator for numerous global pharmaceutical trials involving coagulation factors and anticoagulants. Additionally, she is a co-founder of Zora Biosciences, a diagnostics company focused on lipidomics. Her work has significantly advanced the clinical management of bleeding disorders such as hemophilia and von Willebrand disease. She is recognized as a leading Key Opinion Leader (KOL) in Northern Europe for coagulation medicine.